import time
import random

# --- SIMULATION MODE: EY TECHATHON ARCHITECTURE  ---
# This matches the specific "Worker Agents" defined in your PPT.

# 1. IQVIA INSIGHTS AGENT
def get_iqvia_data(disease):
    print(f"📊 IQVIA Agent: Querying market size and competitor data for {disease}...")
    time.sleep(1)
    return f"Market size for {disease} is $4.5B (CAGR 12%). Top competitors: Novarits, Pfizer. High unmet need in pediatric segments."

# 2. EXIM TRADE AGENT
def get_exim_data(molecule):
    print(f"🚢 EXIM Agent: Analyzing import/export trade flows for {molecule}...")
    time.sleep(1)
    return f"High export volume from India to EU. API sourcing costs have stabilized. Supply chain risk: Low."

# 3. PATENT LANDSCAPE AGENT
def get_patent_data(molecule):
    print(f"⚖️ Patent Agent: Scanning global patent registries for {molecule}...")
    time.sleep(1)
    return f"Primary patent expired in 2023. Freedom-to-Operate (FTO) confirmed for new oral formulations."

# 4. CLINICAL TRIALS AGENT
def get_clinical_data(molecule, disease):
    print(f"🔬 Clinical Agent: Extracting pipeline info for {molecule} + {disease}...")
    time.sleep(1)
    return f"Found 3 Phase II trials with positive efficacy signal. Mechanism of Action (MoA) aligns with {disease} pathways."

# 5. INTERNAL INSIGHTS AGENT
def get_internal_data():
    print(f"📂 Internal Agent: RAG Search across uploaded internal PDFs...")
    time.sleep(1)
    return "Internal R&D docs suggest we have a stable formulation ready for bio-equivalence testing."

# 6. WEB INTELLIGENCE AGENT
def get_web_intel(disease):
    print(f"🌐 Web Intel Agent: Scanning FDA guidelines and real-world evidence...")
    time.sleep(1)
    return "FDA recently released guidance accelerating approvals for this therapeutic area."

# --- THE MASTER AGENT (ORCHESTRATOR)  ---
def run_repurposing_crew(molecule: str, disease: str):
    
    # --- PHASE 1: TASK DECOMPOSITION ---
    print(f"🤖 Master Agent: Receiving request for {molecule} -> {disease}.")
    time.sleep(0.5)
    print(f"🤖 Master Agent: Decomposing strategy into 6 parallel sub-tasks...")
    time.sleep(1)
    
    # --- PHASE 2: PARALLEL EXECUTION (Simulated) ---
    
    # We run the specific agents from your PPT
    iqvia_insight = get_iqvia_data(disease)
    print(f"✅ IQVIA Agent: Task Complete.")
    
    exim_insight = get_exim_data(molecule)
    print(f"✅ EXIM Agent: Task Complete.")
    
    patent_insight = get_patent_data(molecule)
    print(f"✅ Patent Agent: Task Complete.")
    
    clinical_insight = get_clinical_data(molecule, disease)
    print(f"✅ Clinical Agent: Task Complete.")
    
    internal_insight = get_internal_data()
    print(f"✅ Internal Agent: Task Complete.")
    
    web_insight = get_web_intel(disease)
    print(f"✅ Web Intel Agent: Task Complete.")
    
    # --- PHASE 3: SYNTHESIS & REPORTING ---
    print("🧠 Master Agent: Synthesizing all evidence into Strategic Opportunity Map...")
    time.sleep(2)

    # This report structure matches your "Output Form Factor" [cite: 19]
    report = f"""
# Strategic Repurposing Dossier: {molecule}

**Target Indication:** {disease}  
**Recommendation:** **GO (High Priority)** 🟢

## 1. Executive Summary
The **AtreyaCare Agentic System** has identified a high-value opportunity to repurpose **{molecule}**. By triangulating clinical signals with market gaps, we project a **$250M+ revenue opportunity**.

## 2. Multi-Agent Intelligence Findings

### 📊 Market & Competitor Landscape (IQVIA Agent)
* **Market Opportunity:** {iqvia_insight}
* **Commercial Viability:** High. The specific patient segment identified is currently underserved.

### ⚖️ Legal & IP Strategy (Patent Agent)
* **FTO Status:** {patent_insight}
* **Strategy:** File for a "Method of Use" patent immediately to secure 3-year exclusivity.

### 🔬 Clinical Evidence (Clinical Trials Agent)
* **Pipeline Analysis:** {clinical_insight}
* **Safety:** Molecule has a known safety profile, reducing Phase 1 risks.

### 🚢 Supply Chain & Trade (EXIM Agent)
* **Sourcing:** {exim_insight}

### 📂 Internal Proprietary Data (Internal Agent)
* **Knowledge Base:** {internal_insight}

## 3. Strategic Conclusion
This project aligns with corporate strategy. The "Internal Insights" agent confirms we have the formulation capabilities. 
**Next Step:** Initiate Phase 2b bridging study.
    """
    
    return report